Why Do Nasal Polyps Happen? And Why Do They Keep Coming Back?
Produced in collaboration with the Asthma and Allergy Foundation of America
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi
Patients with nasal polyps face a challenging disease course filled with many delays and gaps in care. Even after the relief of a diagnosis, patients often experience disappointment with ineffective treatments. Traditional treatments do not effectively control symptoms and polyps frequently recur, even after functional endoscopic sinus surgery (FESS), the last option for many patients. However, patients may be unaware of all their therapeutic options and potential treatment pathways.
Join us for a new presentation that will explain the therapeutic options and potential treatments for nasal polyps. A panel consisting of expert clinicians, a patient advocate, and a patient with nasal polyps review why and how nasal polyps develop, while exploring how this relates to traditional and new targeted treatments. Learn about the latest recommendations for management of nasal polyps, including how biologic agents compare to surgery on symptom resolution, quality of life, recurrence rates, and adverse events/complications. Patients will learn how to tell their preferences to clinicians and identify specialists who can provide their preferred treatment approaches.
After watching this program, you will understand:
- The process by which nasal polyps develop and how this helps determines if medications will work
- The differences between management strategies in terms of time to symptom resolution, impact on QoL, types and rates of adverse events, and recurrence rates for people with severe, refractory, or recurrent nasal polyps and those who cannot receive oral steroids
- Which clinician specialists commonly treat NPs and what strategies are available to advocate for yourself and obtain treatment that meets your expectations
Severe, Refractory and Recurrent Nasal Polpys After Surgery
Engage to Optimize my Nasal Polyp Treatment
John Bosso, MD
Clinical Professor, Division of Rhinology Department of Otorhinolaryngology: Head and Neck Surgery University of Pennsylvania, Perelman School of Medicine
John V. Bosso, MD, serves as medical director of the Aspirin Exacerbated Respiratory Disease (AERD or Samter’s triad) Center and director of the OTO-Allergy Clinic at Penn Medicine in Philadelphia. He is one of the country’s most experienced AERD super-specialists with over 30 years of expertise in managing this challenging condition. Dr Bosso was one of the first allergy/immunology fellows to learn the techniques of aspirin desensitization and has subsequently successfully desensitized over 1000 AERD patients. His current research focuses on potential causes, molecular mechanisms, and treatments of AERD. Dr Bosso has spoken at national otorhinolaryngology meetings and served on AERD panels. In addition, he is a proud supporter of the Samter’s Society, a support group for AERD sufferers.
Vice President, Corporate Affairs and Research, Asthma and Allergy Foundation of America
Sanaz Eftekhar, vice president of Corporate Affairs and Research at AAFA, leads tactical and strategic conversations with business partners and stakeholders across multiple industries. She has been instrumental in working with AAFA’s partners to present patient perspectives on the needs for atopic dermatitis treatments to the US Food and Drug Administration. In a greater effort to connect patients with vital clinical trials, Sanaz has been a key player in the development of AAFA’s upcoming clinical trial database. She has led AAFA’s involvement in the CIU & You campaign since its launch in 2015, co-authored several key AAFA research reports, and serves as secretary on the Board of Directors for the Global Allergy & Airways Patient Platform (GAAPP).
Noam Cohen, MD, PhD
Professor of Otorhinolaryngology – Head and Neck Surgery
Perelman School of Medicine at The University of Pennsylvania
Noam Cohen, MD, PhD, is the Ralph Butler Professor of Otorhinolaryngology – Head and Neck Surgery and Director of Rhinology Research at the Perelman School of Medicine at The University of Pennsylvania. Additionally, Dr. Cohen is an Adjunct Member of The Monell Chemical Senses Center and a Staff Surgeon at the Philadelphia VA Medical Center. His clinical practice is concentrated on surgical and medical management of diseases of the sinonasal cavity. In addition, Dr. Cohen’s research interests include host-microbe interactions in the upper airway with a focus on sinonasal innate defenses focusing on airway taste receptors and mucociliary clearance, microbial biofilms, solitary chemosensory cells, and the development of novel sinonasal topical antimicrobial therapies.
Patient with Nasal Polyps, Asthma, and Allergies
Missy Canty currently resides in South Carolina with her children, four boys and two girls. Her education consists of a bachelor's degree in Journalism and Mass Communications. Missy has been employed in the customer service industry with SITEL Group for six years. Since 2015, Missy has been living with nasal polyps. In addition, she suffers from outdoor allergens, asthma, and chronic sinusitis. For Missy, living with these conditions has interfered with her family, work, and social life. Furthermore, Missy has endured multiple treatment options such as endoscopic sinus surgery, immunotherapy shots, sinus rinses, and prednisone to fight against her nasal polyps. Currently, Missy’s treatment includes a biologic, which has been the most effective at combating nasal polyps for her.
Interview Participant - Patient with sinus and nasal polyps